Press Releases
Drug Research
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Cipla Limited, Dr. Reddyโs Laboratories Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, and Torrent Pharmaceuticals Limited, announced that the five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of...
Drug Research
Sanofi launches dedicated vaccines mRNA Center of Excellence
Sanofi will invest approximately โฌ400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development and delivery of next-generation vaccines by bringing together approximately 400 dedicated employees integrating end-to-end mRNA...
Press Releases
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the government of India has issued a registration certificate and a permission to import the COVID-19 Vaccine Moderna for restricted use in an emergency situation.
โI...
Press Releases
Roche’s Actemra/RoActemra receives U.S. FDA EUA for the treatment of COVID-19 in hospitalised adults and children
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemraยฎ (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental...
Clinical Trials
CluePoints Launch Post-COVID Trial Assurance Solution
CluePoints, the premier provider ofย Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission to build safer, more efficient trials for patients, sponsors and, CROs.
The pandemic has been the...
Drug Research
Roches Actemra/RoActemra receives U.S. FDA EUA for the treatment of COVID-19 in hospitalised adults and children
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemraยฎ (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental...
Press Releases
Drug delivery innovation across Europe improves for third consecutive year ahead of Pharmapack Europe
Ahead of Pharmapack Europe 2021 (Paris Expo, Porte de Versailles, 13-14 October) โ the returning European event dedicated to drug packaging and delivery โ there has been a huge swathe of innovation across the industry, with more than 53...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














